Comparative diagnostic accuracy of 18F-FDG PET/CT for breast cancer recurrence

References

• TaghipourMWrayRSheikhbahaeiSWrightJLSubramaniamRMFDG avidity and tumor burden: survival outcomes for patients with recurrent breast cancerAJR Am J Roentgenol2016206484685527003053
   PubMed Web of Science ®Google Scholar
• FerlayJSoerjomataramIErvikMGLOBOCAN 2012 v1.0. Cancer incidence and mortality worldwideLyon, FranceIARC CancerBase No. 112012
   Google Scholar
• KitajimaKFukushimaKMiyoshiYAssociation between 18F-FDG uptake and molecular subtype of breast cancerEur J Nucl Med Mol Imaging20154291371137725947575
   PubMed Web of Science ®Google Scholar
• AminMBEdgeSGreeneFLAJCC Cancer Staging ManualNew York, NYSpringer2002
   Google Scholar
• ArvoldNDTaghianAGNiemierkoAAge, breast cancer subtype approximation and local recurrence after breast-conserving therapyJ Clin Oncol201129293885389121900114
   PubMed Web of Science ®Google Scholar
• LakhaniSREllisIOSchnittSWHO Classification of Tumours4th edLyonIARC Press2012
   Google Scholar
• GoldhirschAWoodWCCoatesASGelberRDThürlimannBSennHJStrategies for subtypes-dealing with the diversity of breast cancer: highlights of the St. Gallen international expert consensus on the primary therapy of early breast cancer 2011Ann Oncol20112281736174721709140
   PubMed Web of Science ®Google Scholar
• PerouCMSørlieTEisenMBMolecular portraits of human breast tumoursNature2000406679774775210963602
   PubMed Web of Science ®Google Scholar
• VoducKDCheangCUTyldesleySBreast cancer subtypes and the risk of local and regional relapseJ Clin Oncol201028101684169120194857
   PubMed Web of Science ®Google Scholar
• DaiXLiTBaiZBreast cancer intrinsic subtype classification, clinical use and future trendsAm J Cancer Res20155102929294326693050
   PubMed Web of Science ®Google Scholar
• YilmazZNNealCHNoroozianMImaging of breast cancer–related changes after nonsurgical therapyAJR Am J Roentgenol2014202367568324555607
   PubMed Web of Science ®Google Scholar
• National Collaborating Centre for CancerEarly and Locally Advanced Breast Cancer: Diagnosis and TreatmentCardiff, WalesNational Collaborating Centre for Cancer2009
   Google Scholar
• KimSJMoonWKChoNChangJMThe detection of recurrent breast cancer in patients with a history of breast cancer surgery: comparison of clinical breast examination, mammography and ultrasonographyActa Radiol2011521152021498320
   PubMed Web of Science ®Google Scholar
• De BockGHBonnemaJvan der HageJKievitJvan de VeldeCJEffectiveness of routine visits and routine tests in detecting isolated locoregional recurrences after treatment for early stage invasive breast cancer: a meta-analysis and systematic reviewJ Clin Oncol200422194010401815459225
   PubMed Web of Science ®Google Scholar
• KhatcheressianJLWolffACSmithTJAmerican society of clinical oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant settingJ Clin Oncol200624315091509717033037
   PubMed Web of Science ®Google Scholar
• GaetaCMVercher-ConejeroJLSherACKohanARubbertCAvrilNRecurrent and metastatic breast cancer PET, PET/CT, PET/MRI: FDG and new biomarkersQ J Nucl Med Mol Imaging201357435236624322792
   PubMed Web of Science ®Google Scholar
• HoussamiNTurnerRMRapid review: estimates of incremental breast cancer detection from tomosynthesis (3D-mammography) screening in women with dense breastsBreast20163014114527721194
   PubMed Web of Science ®Google Scholar
• MellinkWAHollandRHendriksJHPeetersPHRutgersEJvan DaalWAThe contribution of routine follow-up mammography to an early detection of asynchronous contralateral breast cancerCancer1991677184418481848469
   PubMed Web of Science ®Google Scholar
• PredaLVillaGRizzoSMagnetic resonance mammography in the evaluation of recurrence at the prior lumpectomy site after conservative surgery and radiotherapyBreast Cancer Res200685R5316959028
   PubMed Web of Science ®Google Scholar
• MoonHJKimMJKimEKUS surveillance of regional lymph node recurrence after breast cancer surgeryRadiology2009252367368119546429
   PubMed Web of Science ®Google Scholar
• KimMJKimEKKwakJYRole of sonography in the detection of contralateral metachronous breast cancer in an Asian populationAm J Roentgenol2008190247648018212235
   PubMed Web of Science ®Google Scholar
• RobertsonCRagupathySKBoachieCSurveillance mammography for detecting ipsilateral breast tumour recurrence and meta-chronous contralateral breast cancer: a systematic reviewEur Radiol201121122484249121833567
   PubMed Web of Science ®Google Scholar
• ConstanceDLACR Practice guideline for the performance of contrast enhanced magnetic resonance imaging of the breastACR2013
   Google Scholar
• KriegeMBrekelmansCTBoetesCEfficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predispositionN Engl J Med2004351542743715282350
   PubMed Web of Science ®Google Scholar
• LeachMOBoggisCRDixonAKScreening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS)Lancet200536594731769177815910949
   PubMed Web of Science ®Google Scholar
• LehmanCDBlumeJDWeatherallPScreening women at high risk for breast cancer with mammography and magnetic resonance imagingCancer200510391898190515800894
   PubMed Web of Science ®Google Scholar
• MenellJHMorrisEADershawDDAbramsonAFBrogiELibermanLDetermination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imagingBreast J200511638239016297080
   PubMed Web of Science ®Google Scholar
• WarnerEPlewesDBHillKASurveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography and clinical breast examinationJAMA2004292111317132515367553
   PubMed Web of Science ®Google Scholar
• Metzger-FilhoOSunZVialeGPatterns of recurrence and outcome according to breast cancer subtypes in lymph node-negative disease: results from international breast cancer study group trials VIII and IXJ Clin J Cancer Res Clin Oncol2010136710071022
   Google Scholar
• KobayashiTIchibaTSakuyamaTPossible clinical cure of metastatic breast cancer: lessons from our 30-year experience with oligometastatic breast cancer patients and literature reviewBreast Cancer201219321823722532161
   PubMed Web of Science ®Google Scholar
• YilmazZNNealCHNoroozianMImaging of breast cancer–related changes after nonsurgical therapyAJR Am J Roentgenol2014202367568324555607
   PubMed Web of Science ®Google Scholar
• KambyCVejborgIKristensenBMetastatic pattern in recurrent breast cancer: special reference to intrathoracic recurrencesCancer19886210222622333179937
   PubMed Web of Science ®Google Scholar
• ClézardinPTherapeutic targets for bone metastases in breast cancerBreast Cancer Res201113220721586099
   PubMed Web of Science ®Google Scholar
• SchirrmeisterHDetection of bone metastases in breast cancer by positron emission tomographyRadiol Clin North Am200745466967617706531
   PubMed Web of Science ®Google Scholar
• HamaokaTMadewellJEPodoloffDAHortobagyiGNUenoNTBone imaging in metastatic breast cancerJ Clin Oncol200422142942295315254062
   PubMed Web of Science ®Google Scholar
• ColemanRESkeletal complications of malignancyCancer199780Suppl158815949362426
   PubMed Web of Science ®Google Scholar
• CookGJAzadGKGohVImaging bone metastases in breast cancer: staging and response assessmentJ Nucl Med201657Suppl 127S33S26834098
   PubMed Web of Science ®Google Scholar
• CapitanioSBongioanniFPiccardoAComparisons between glucose analogue 2-deoxy-2(18F)fluoro-D-glucose and 18F-sodium fluoride positron emission tomography/computed tomography in breast cancer patients with bone lesionsWorld J Radiol20168220020926981229
   PubMedGoogle Scholar
• LiuTWangSLiuHDetection of vertebral metastases: a meta-analysis comparing MRI, CT, PET, BS and BS with SPECTJ Cancer Res Clin Oncol2017143345746527752772
   PubMed Web of Science ®Google Scholar
• YangHLLiuTWangXMXuYDengSMDiagnosis of bone metastases: a meta-analysis comparing ¹8FDG PET, CT, MRI and bone scintigraphyEur Radiol201121122604261721887484
   PubMed Web of Science ®Google Scholar
• SenkusEKyriakidesSOhnoSESMO Guidelines CommitteePrimary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-upAnn Oncol201526Suppl 5v8v3026314782
   PubMed Web of Science ®Google Scholar
• CardosoFHarbeckNFallowfieldLKyriakidesSSenkusEESMO guidelines working groupLocally recurrent or metastatic breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and followupAnn Oncol201223Suppl 7VII11922997442
   PubMed Web of Science ®Google Scholar
• GradisharWJAndersonBOBalassanianRNCCN Guidelines insights breast cancer, version1. 2016J Nat Compr Canc Netw2015131214751485
   Web of Science ®Google Scholar
• ChangH-THuCChiuY-LPengN-JLiuR-SRole of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancerPLoS One2014912e11512725517451
   PubMed Web of Science ®Google Scholar
• Gil-RendoAMartínez-RegueiraFZornozaGGarcía-VellosoMJBeorleguiCRodriguez-SpiteriNAssociation between [18F] fluorodeoxyglucose uptake and prognostic parameters in breast cancerBr J Surg200996216617019160365
   PubMed Web of Science ®Google Scholar
• EvangelistaLCervinoARGhiottoCAl-NahhasARubelloDMuzzioPC Tumor marker-guided PET in breast cancer patients-a recipe for a perfect wedding: a systematic literature review and meta-analysisClin Nucl Med201237546747422475896
   PubMed Web of Science ®Google Scholar
• FilippiVMalamitsiJVlachouFThe impact of FDG-PET/CT on the management of breast cancer patients with elevated tumor markers and negative or equivocal conventional imaging modalitiesNucl Med Commun2011322859021127445
   PubMed Web of Science ®Google Scholar
• RadanLBen-HaimSBar-ShalomRThe role of FDG-PET/CT in suspected recurrence of breast cancerCancer2006107112545255117063499
   PubMed Web of Science ®Google Scholar
• AukemaTSRutgersEJTVogelWVThe role of FDG PET/CT in patients with locoregional breast cancer recurrence: a comparison to conventional imaging techniquesEur J Surg Oncol201036438739219962268
   PubMed Web of Science ®Google Scholar
• DirisamerAHalpernBSFlöryDIntegrated contrast-enhanced diagnostic whole-body PET/CT as a first-line restaging modality in patients with suspected metastatic recurrence of breast cancerEur J Radiol201073229429919181468
   PubMed Web of Science ®Google Scholar
• SchmidtGPBaur-MelnykAHaugAComprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CTEur J Radiol2008651475818082989
   PubMed Web of Science ®Google Scholar
• GebhartGGámezCHolmesE18 F-FDG PET/CT for early prediction of response to neoadjuvant Lapatinib, Trastuzumab, and their combination in HER2-Positive breast cancer: results from Neo-ALTTOJ Nucl Med201354111862186824092940
   PubMed Web of Science ®Google Scholar
• SuárezMPérez-CastejónMJJiménezAEarly diagnosis of recurrent breast cancer with FDG-PET in patients with progressive elevation of serum tumor markersQ J Nucl Med200246211312112114874
   PubMedGoogle Scholar
• LiuTChengTXuWA meta-analysis of 18FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with breast cancerSkeletal Radiol201140552353120495798
   PubMed Web of Science ®Google Scholar
• EubankWBMankoffDATakasugiJVesselleH18Fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancerJ Clin Oncol200119153516352311481358
   PubMed Web of Science ®Google Scholar
• CochetADygai-CochetIRiedingerJM18F-FDG PET/CT provides powerful prognostic stratification in the primary staging of large breast cancer when compared with conventional explorationsEur J Nucl Med Mol Imaging201441342843724196916
   PubMed Web of Science ®Google Scholar
• DoseJBleckmannCBachmannSComparison of fluorodeoxyglucose positron emission tomography and “conventional diagnostic procedures’’ for the detection of distant metastases in breast cancer patientsNucl Med Commun200223985786412195090
   PubMed Web of Science ®Google Scholar
• MahnerSSchirrmacherSBrennerWComparison between positron emission tomography using 2-[fluorine-18]fluoro-2-deoxy-D-glucose, conventional imaging and computed tomography for staging of breast cancerAnn Oncol20081971249125418356138
   PubMed Web of Science ®Google Scholar
• MorbelliSConziRCampusCContrast-enhanced [18 F] fluorodeoxyglucose-positron emission tomography/computed tomography in clinical oncology: tumor-, site-, and question-based comparison with standard positron emission tomography/computed tomographyCancer Imaging20141411025609564
   PubMed Web of Science ®Google Scholar
• DonatiOFHanyTFReinerCSValue of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRIJ Nucl Med201051569269920395324
   PubMed Web of Science ®Google Scholar
• PivotXAsmarLHortobagyiGNTheriaultRPastoriniFBuzdarAA retrospective study of first indicators of breast cancer recurrenceOncology200058318519010765118
   PubMed Web of Science ®Google Scholar
• ViadanaECotterRPickrenJWBrossIDAn autopsy study of metastatic sites of breast cancerCancer Res19733311791814682319
   PubMed Web of Science ®Google Scholar
• CookGJHoustonSRubensRMaiseyMNFogelmanIDetection of bone metastases in breast cancer by FDG PET: differing metabolic activity in osteoblastic and osteolytic lesionsJ Clin Oncol19981610337533799779715
   PubMed Web of Science ®Google Scholar
• AbeKSasakiMKuwabaraYComparison of 18FDG-PET with 99mTc-HMDP scintigraphy for the detection of bone metastases in patients with breast cancerAnn Nucl Med200519757357916363622
   PubMed Web of Science ®Google Scholar
• NakaiTOkuyamaCKubotaTPitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancerEur J Nucl Med Mol Imaging200532111253125816133397
   PubMed Web of Science ®Google Scholar
• DashevskyBZGoldmanDAParsonsMAppearance of untreated bone metastases from breast cancer on FDG PET/CT: importance of histologic subtypeEur J Nucl Med Mol Imaging201542111666167325971426
   PubMed Web of Science ®Google Scholar
• IsraelOGoldbergANachtigalAFDG-PET and CT patterns of bone metastases and their relationship to previously administered anticancer therapyEur J Nucl Med Mol Imaging200633111280128416791597
   PubMed Web of Science ®Google Scholar
• TateishiUGamezCDawoodSYeungHWCristofanilliMMacapinlacHABone metastases in patients with metastatic breast cancer: morphologic and metabolic monitoring of response to systemic therapy with integrated PET/CTRadiology2008247118919618372468
   PubMed Web of Science ®Google Scholar
• CookGJHoustonSRubensRMaiseyMNFogelmanIDetection of bone metastases in breast cancer by FDG PET: differing metabolic activity in osteoblastic and osteolytic lesionsJ Clin Oncol19981610337533799779715
   PubMed Web of Science ®Google Scholar
• HahnSHeusnerTKümmelSComparison of FDG-PET/CT and bone scintigraphy for detection of bone metastases in breast cancerActa Radiol20115291009101421969709
   PubMed Web of Science ®Google Scholar
• OhtaMTokudaYSuzukiYWhole body PET for the evaluation of bone metastases in patients with breast cancer: comparison with 99Tcm-MDP bone scintigraphyNucl Med Commun200122887587911473206
   PubMed Web of Science ®Google Scholar
• ShiePCardarelliRBrandonDErdmanWAbdulrahimNMeta-analysis: comparison of F-18 fluorodeoxyglucose-positron emission tomography and bone scintigraphy in the detection of bone metastases in patients with breast cancerClin Nucl Med20083329710118209527
   PubMed Web of Science ®Google Scholar
• RongJWangSDingQYunMZhengZYeSComparison of 18FDG PET-CT and bone scintigraphy for detection of bone metastases in breast cancer patients: a meta-analysisSurg Oncol2013222869123726506
   PubMed Web of Science ®Google Scholar
• YapCSSeltzerMASchiepersCImpact of whole-body 18F-FDG PET on staging and managing patients with breast cancer: the referring physician’s perspectiveJ Nucl Med20014291334133711535721
   PubMed Web of Science ®Google Scholar
• MitchellJMLagaliaRRControlling the escalating use of advanced-imaging: the role of radiology benefit management programsMed Care Res Rev200966333935119208823
   PubMed Web of Science ®Google Scholar
• GroheuxDMartineauATeixeiraL18FDG-PET/CT for predicting the outcome in ER+/HER2-breast cancer patients: comparison of clinicopathological parameters and PET image-derived indices including tumor texture analysisBreast Cancer Res2017191328057031
   PubMed Web of Science ®Google Scholar
• GroheuxDSannaAMajdoubMBaseline tumor 18F-FDG uptake and modifications after 2 cycles of neoadjuvant chemotherapy are prognostic of outcome in ER+/HER2-breast cancerJ Nucl Med201556682483125883123
   PubMed Web of Science ®Google Scholar
• HattMGroheuxDMartineauAComparison between 18F-FDG PET image-derived indices for early prediction of response to neoadjuvant chemotherapy in breast cancerJ Nucl Med201354334134923327900
   PubMed Web of Science ®Google Scholar
• GroheuxDHattMHindiéEEstrogen receptor-positive/human epidermal growth factor receptor 2-negative breast tumors: early prediction of chemosensitivity with (18) F-fluorodeoxyglucose positron emission tomography/computed tomography during neoadjuvant chemotherapyCancer2013119111960196823504954
   PubMed Web of Science ®Google Scholar
• GroheuxDMajdoubMSannaAEarly metabolic response to neoadjuvant treatment: FDG PET/CT criteria according to breast cancer subtypeRadiology2015277235837125915099
   PubMed Web of Science ®Google Scholar
• SoussanMOrlhacFBoubayaMRelationship between tumor heterogeneity measured on FDG-PET/CT and pathological prognostic factors in invasive breast cancerPLoS One201494e9401724722644
   PubMed Web of Science ®Google Scholar
• SonSHKimDHHongCMPrognostic implication of intra-tumoral metabolic heterogeneity in invasive ductal carcinoma of the breastBMC Cancer201414158525112709
   PubMed Web of Science ®Google Scholar
• HeSWangMYangZComparison of 18F-FES, 18F-FDG and 18F-FMISO PET imaging probes for early prediction and monitoring of response to endocrine therapy in a mouse xenograft model of ER-positive breast cancerPLoS One2016117e015991627467716
   PubMed Web of Science ®Google Scholar
• Hong-LiCXiao-ChunWJiang-BinWJing-BoZYaoWQuality of life in patients with breast cancer and their rehabilitation needsPak J Med Sci201430112613024639845
   PubMed Web of Science ®Google Scholar
• GanzPASurvivorship: adult cancer survivorsPrim Care200936472174119913184
   PubMed Web of Science ®Google Scholar
• RunowiczCDLeachCRHenryNLAmerican cancer society/American society of clinical oncology breast cancer survivorship care guidelineJ Clin Oncol201634661163526644543
   PubMed Web of Science ®Google Scholar
• AugustePBartonPHydeCRobertsTEAn economic evaluation of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrenceHealth Technol Assess20111518iiiiv154
   Web of Science ®Google Scholar
• SimardSThewesBHumphrisGFear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studiesJ Cancer Surviv20137330032223475398
   PubMed Web of Science ®Google Scholar
• PuglisiFFontanellaCNumicoGFollow-up of patients with early breast cancer: is it time to rewrite the story?Crit Rev Oncol Hematol201491213014124726438
   PubMed Web of Science ®Google Scholar
• ConstantinidouAMartinASharmaBJohnstonSRPositron emission tomography/computed tomography in the management of recurrent/metastatic breast cancer: a large retrospective study from the Royal Marsden HospitalAnn Oncol201122230731420624786
   PubMed Web of Science ®Google Scholar
• GallowitschHJKresnikEGasserJF-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imagingInvest Radiol200338525025612750613
   PubMed Web of Science ®Google Scholar